If not administered properly, the GLP-1 medication can cause nausea, abdominal pain, and cramps, possibly leading to dehydration. The doses are normally taken a week apart, so not waiting long enough ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

or severe abdominal pain. The usual beginners' dose of Mounjaro is 2.5 milligrams once a week for the first 4 weeks [7]. Some doctors will continue to increase the dosage as much as 2.5 mg every 4 ...

But Mounjaro can cause certain conditions that have back pain or abdominal pain as symptoms. For example, Mounjaro may raise your risk of pancreatitis. Symptoms of pancreatitis may include back ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Clinical trials have found that people who are on the prescription for a year can lose more than 10% of their body weight.

Examples of commonly reported side effects include nausea, vomiting, abdominal pain, and diarrhea. See “What are the mild side effects of Mounjaro?” and “What are the serious side effects of ...

Eli Lilly plans to launch Mounjaro, an anti-diabetes and weight loss drug, in India by 2025. The medication, which is ...

According to a Healthline report, consumption of Mounjaro may have several consequences, such as vomiting, diarrhea, decreased appetite, indigestion, abdominal pain and other rare side effects ...

A new study published in the journal JAMA Psychiatry found that semaglutide (sold under brand names like Ozempic and Wegovy) can help curb alcohol cravings. But the limitations of the study, such as ...

WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...